/Companies

VERAVANTI INC.

Bothell, US · Founded 2013

Find your way into VERAVANTI INC.

Sign up to see every warm intro you have to VERAVANTI INC.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the VERAVANTI INC. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

VerAvanti develops ultra-small, single-use endoscopic imaging devices using patented scanning fiber technology for minimally invasive procedures. The company focuses on enabling clearer visualization and more efficient workflows for physicians during diagnostic and therapeutic interventions.

Founders & leadership

VERAVANTI INC. was founded in 2013 by Gerald McMorrow.

GM
Gerald McMorrowFounder and CEO
ESEric Siebel
Eric SiebelExecutive
JVJuan Vegarra
Juan VegarraChief Revenue Officer & Acting CFOJuan Vegarra is Chief Revenue Officer and Acting CFO at VerAvanti Inc., which commercializes a hardware-enabled AI platform for interventional imaging. Previously, he held roles at Microsoft including Worldwide Director of the Solution Provider Program, led Vena Resources from a $500K seed to $160M peak market capitalization, and worked as a software developer on the ICU Research team at George Washington University Medical School.
LS
Luis SavastanoExecutive
DG
David GoeslingExecutive
RG
Russell GarrisonExecutive

Board

FMFrederic Moll
Frederic MollBoard directorGeneral Partner at Sonder Futures
MM
Michael MoyerBoard director
DA
David AuthBoard director

Reported raises · per SEC filings

Form D private placements

$28.9M disclosed across 2 rounds · 2017–2025

▶$28.3MraisedMar 2025 · 17 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Frederic MollDirector
  • Michael MoyerDirector
  • Eric SiebelExecutive Officer
  • Juan VegarraExecutive Officer
  • Luis SavastanoExecutive Officer
  • David AuthDirector
  • David GoeslingExecutive Officer
  • Gerald McMorrowExecutive Officer, Director
Offering amount
$37.3M
Amount sold
$28.3M
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$540KraisedMay 2017 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gerald McMorrowExecutive Officer, Director, Promoter
  • Russell GarrisonExecutive Officer, Director
  • David AuthDirector
Offering amount
$5M
Amount sold
$540K
Minimum investment
$60K
First sale
May 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$2M
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$300K
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$286.1K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does VERAVANTI INC. do?
VerAvanti develops ultra-small, single-use endoscopic imaging devices using patented scanning fiber technology for minimally invasive procedures. The company focuses on enabling clearer visualization and more efficient workflows for physicians during diagnostic and therapeutic interventions.
Who founded VERAVANTI INC.?
VERAVANTI INC. was founded by Gerald McMorrow in 2013.
How much funding has VERAVANTI INC. raised?
VERAVANTI INC. has disclosed $28.9M raised across 2 rounds.
Where is VERAVANTI INC. headquartered?
VERAVANTI INC. is headquartered in Bothell, US.